Previous Section Index Home Page

12 Oct 2009 : Column 748W—continued


12 Oct 2009 : Column 749W


12 Oct 2009 : Column 750W
Diseases of the respiratory system
Diagnosis code Primary description

J00

Acute nasopharyngitis (common cold)

J01

Acute sinusitis

J02

Acute pharyngitis

J03

Acute tonsillitis

J04

Acute laryngitis and tracheitis

J05

Acute obstructive laryngitis (croup) and epiglottitis

J06

Acute upper respiratory infections of multiple and unspecified sites

J10

Influenza due to identified influenza virus

J11

Influenzavirus not identified

J12

Viral pneumonia, not elsewhere classified

J13

Pneumonia due to Streptococcus pneumoniae

J14

Pneumonia due to Haemophilus influenzae

J15

Bacterial pneumonianot elsewhere classified

J16

Pneumonia due to other infectious organisms NEC

J17

Pneumonia in diseases classified elsewhere

J18

Pneumoniaorganism unspecified

J20

Acute bronchitis

J21

Acute bronchiolitis

J22

Unspecified acute lower respiratory infection

J30

Vasomotor and allergic rhinitis

J31

Chronic rhinitisnasopharyngitis and pharyngitis

J32

Chronic sinusitis

J33

Nasal polyp

J34

Other disorders of nose and nasal sinuses

J35

Chronic diseases of tonsils and adenoids

J36

Peritonsillar abscess

J37

Chronic laryngitis and laryngotracheitis

J38

Diseases of vocal cords and larynx not elsewhere class

J39

Other diseases of upper respiratory tract

J40

Bronchitis not specified as acute or chronic

J41

Simple and mucopurulent chronic bronchitis

J42

Unspecified chronic bronchitis

J43

Emphysema

J44

Other chronic obstructive pulmonary disease

J45

Asthma

J46

Status asthmaticus

J47

Bronchiectasis

J60

Coalworker's pneumoconiosis

J61

Pneumoconiosis due to asbestos and other mineral fibres

J62

Pneumoconiosis due to dust containing silica

J63

Pneumoconiosis due to other inorganic dusts

J64

Unspecified pneumoconiosis

J65

Pneumoconiosis associated with tuberculosis

J66

Airway disease due to specific organic dust

J67

Hypersensitivity pneumonitis due to organic dust

J68

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

J69

Pneumonitis due to solids and liquids

J70

Respiratory conditions due to other external agents

J80

Adult respiratory distress syndrome

J81

Pulmonary oedema

J82

Pulmonary eosinophilia, not elsewhere classified

J84

Other interstitial pulmonary diseases

J85

Abscess of lung and mediastinum

J86

Pyothorax

J90

Pleural effusionnot elsewhere classified

J91

Pleural effusion in conditions classified elsewhere

J92

Pleural plaque

J93

Pneumothorax

J94

Other pleural conditions

J95

Postprocedural respiratory disorders NEC

J96

Respiratory failure not elsewhere classified

J98

Other respiratory disorders

J99

Respiratory disorders in diseases classified elsewhere


Rheumatology

Mr. Stephen O'Brien: To ask the Secretary of State for Health what estimate he has made of the number of (a) inpatient and (b) outpatient attendances in the rheumatology speciality in the latest year for which figures are available; and at what average cost. [289457]

Phil Hope: We have made no estimate of the number, or cost, of in-patient and out-patient attendances for rheumatology.

However, the total number of ordinary, and day case admissions, to hospital where the main consultant specialty is recorded as rheumatology is given in the following table.

Day case Ordinary

2006-07

62,707

31,577

2005-06

56,938

32,277

2004-05

53,183

31,530

2003-04

49,003

31,440

2002-03

41,003

32,279

2001-02

33,041

34,056

2000-01

30,331

35,524

1999-2000

27,275

37,033

1998-99

24,045

36,968

1997-98

20,496

38,976

1996-97

17,538

40,053

Note:
A finished admission episode is the first period of in-patient care under one consultant within one health care provider. Finished admission episodes are counted against the year in which the admission episode finishes. Admissions do not represent the number of in-patients, as a person may have more than one admission within the year.

Schizophrenia

Lynne Jones: To ask the Secretary of State for Health (1) what proportion of mental health NHS provider organisations are implementing the National Institute for Health and Clinical Excellence clinical guideline update for schizophrenia; [290314]

(2) what steps he is taking to (a) publicise and (b) implement the recommendations of the updated National Institute for Health and Clinical Excellence clinical guideline update for schizophrenia; [290315]

(3) what (a) support and (b) guidance has been made available to healthcare professionals to facilitate adherence to the National Institute for Health and Clinical Excellence clinical guideline update on schizophrenia; and whether he has put in place ongoing monitoring to assess the implementation of the guidance by healthcare professionals. [290316]


12 Oct 2009 : Column 751W

Phil Hope: We welcome the National Institute for Health and Clinical Excellence's (NICE's) updated guidance on schizophrenia and expect it to help further improve the quality of treatment and care for people with schizophrenia.

It is for NICE to publicise the release of its guidance to the national health service and it is for the NHS to implement it. NICE publishes implementation tools to help the NHS implement its guidance locally.

Clinicians are responsible for deciding on the most appropriate form of treatment for their patients, and in doing so they are expected to take NICE guidance fully into account. The Department does not become involved in clinical decisions, nor does it collect data on implementation levels of this NICE guidance among NHS organisations.

NICE issues both technology appraisals (TAs) and clinical guidelines (CGs) and the schizophrenia guidance issued this March is a CG. Clinicians are expected to consider treatments outlined in CGs when considering prescribing options, but are not obliged to prescribe these. As CGs are very broad in approach and can contain 100 or more recommendations, health bodies should implement the guidance as and when resources permit.

Lynne Jones: To ask the Secretary of State for Health how the Care Quality Commission is monitoring adherence to the National Institute for Health and Clinical Excellence clinical guideline update on schizophrenia; and what steps it will take in respect of NHS organisations found to be non-compliant. [290317]

Phil Hope: There are no plans for the Care Quality Commission to monitor adherence with the clinical guideline on schizophrenia published by the National Institute for Health and Clinical Excellence (NICE).

NICE clinical guidelines support national health service commissioning and best practice in service provision, but compliance with these are not direct indicators of levels of safety and quality. The Department expects NHS organisations to work towards full implementation
12 Oct 2009 : Column 752W
of NICE clinical guidelines over a reasonable period of time using available resources.

Schools: Nurses

Greg Mulholland: To ask the Secretary of State for Health what estimate he has made of the number of secondary schools which employ a school nurse; and what estimate he has made of the number of school nurse posts to be established in secondary schools in the next 12 months. [292116]

Phil Hope: There are about 3,000 secondary schools. The 2008 NHS Workforce Census shows there were 3,643 qualified nurses in school nursing areas (2,634 full time equivalent), an increase of 63 per cent. since 2004. Of these, there were 1,447 (headcount) school nurses with a post registration school nurse qualification (1,062 full time equivalent), an increase of 69 per cent. since 2004.

It is for individual primary care trusts to determine how to use the funding allocated to them to commission services to meet the health care needs of their local populations over the next 12 months.

The overall number of professionals within community services for children and families has increased. School nurses are able to access more resources than was traditionally the case.

Smoking: Greater Manchester

Mr. Crausby: To ask the Secretary of State for Health how many people in (a) Bolton and (b) Greater Manchester have received assistance from the NHS to stop smoking in each of the last five years. [291645]

Gillian Merron: The information is not available in the format requested. The following table shows the number of people setting a quit date and the number of those who successfully quit smoking through national health service stop smoking services in the Bolton primary care trust (PCT) and Greater Manchester, 2004-05 to 2008-09.


Next Section Index Home Page